International views of the use of calcium antagonists in the treatment of hypertension.
L
L
Hansson
K
K
Aoki
F R
FR
Bühler
J H
JH
Laragh
W J
WJ
Louis
A
A
Zanchetti
D000375:Aging; D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D044383:Black People; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D002490:Central Nervous System / Q000187:drug effects; D004359:Drug Therapy, Combination; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006321:Heart / Q000187:drug effects; D006801:Humans; D012083:Renin / Q000097:blood; D013565:Sympatholytics / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D005730:Ganglionic Blockers; D013565:Sympatholytics; D012083:Renin